TIMP1 and metabolic dysfunction-associated steatotic liver disease: One retrospective analysis validated a combined algorithm combining the alpha-2 macroglobulin, hyaluronic acid, and TIMP1 testing across 396 biopsy-proven NAFLD patients [24].